Apostolos Georgopoulos, Regents Professor of neuroscience and neurology, has found patterns in the brain's magnetic signals associated with several brain disorders.
An orderly test for brain disorders
Apostolos Georgopoulos can spot the signs of several mental conditions in the magnetic activity of the brain
By Deane Morrison
October 26, 2007
People with brain disorders like schizophrenia, Alzheimer's disease, or multiple sclerosis may not be able to tell a doctor what's bothering them. But now their brain cells can, thanks to some ingenious detective work by University researcher Apostolos Georgopoulos. Using a technique called magnetoencephalography (MEG), Georgopoulos and his research team were able to find patterns of magnetic activity in the brain's cerebral cortex that reliably signalled the presence of those three disorders, plus chronic alcoholism, Sj?gren's syndrome, facial pain, and normal brain function. The work was published in August in the Journal of Neural Engineering. The technique is the first to measure how the brain functions in real time. It may lead to a noninvasive test of brain function that could spot trouble in the early stages or monitor progress as patients undergo treatment. Already, Georgopoulos has found that the brain patterns of people with chronic alcoholism tend to revert toward normal as they abstain from alcohol. "I did not expect to find this," says Georgopoulos, a Regents Professor of neuroscience and neurology. "It's like a silent movie of the brain." Georgopoulos is also director of the Brain Sciences Center at the Minneapolis Veterans Affairs Medical Center, where he holds the American Legion Brain Sciences Chair.
A salty tale
MEG works by picking up magnetic fields generated by ions--mostly sodium, a constituent of table salt--as they cross membranes of neurons. The membranes are in the fingerlike projections of neurons called dendrites, which function as receivers for messages from other cells. It takes the coherent motion of at least 10,000 or so ions to produce a signal strong enough to detect.
"The dynamic function of the brain has been my obsession for years. For me, the biggest challenge is to find how the brain works on the millisecond level with all the 'buzzing' going on."--Apostolos Georgopoulos"[This work] came out of my strong belief that the real function of the brain is in the interaction of its elements--that is, in the crosstalk," says Georgopoulos. "Exchange of information is the essence of brain function, which is defined as all interactions among all populations of cells. "The dynamic function of the brain has been my obsession for years. For me, the biggest challenge is to find how the brain works on the millisecond level with all the 'buzzing' going on." The emphasis on populations of cells is no accident. For many years, neuroscientists have recorded the activities of single neurons. But our brains are more like a vast array of neural choruses, each consisting of many neurons that sing together and respond to other choruses. Or, on a more prosaic note, one might say that the real work of the brain is done by committees. Georgopoulos and his colleagues are now beginning long-term studies to see if they can predict the onset of Alzheimer's disease. They are also expanding their studies to include depression, fetal alcohol syndrome, gambling, and mild cognitive impairment of various kinds. And they've started taking data on a wide swath of healthy volunteers between the ages of 8 and 100. "He is a huge asset to the University, not only because of how smart he is but because of how collaborative he is," says S. Charles Schulz, head of the psychiatry department. Schulz and Georgopoulos are studying brain disorders by means of MRI and neuropsychological data, which is taken from pencil and paper or computer tests of traits like attention, memory, and decision-making. "In a preliminary study, we could differentiate young people with schizophrenia or bipolar disorder from controls," says Schulz. "That is important in the early stages because clinical [signs] are not really clear." The two are now working to test statistical techniques to see if they can determine, when a schizophrenia patient first visits, what the early response to medication will be so treatment can be better tailored to the patient.